Ivy Rx Review: It Publishes Who Compounds Its Medication — Which Almost Nobody in This Market Does

What Is Ivy Rx?

Ivy Rx, PLLC is a telehealth platform operating from Miami, Florida, founded in 2023 by Phong Truong, PharmD. It sells compounded GLP-1 medication alongside brand-name Ozempic, Mounjaro and metformin, plus a longevity line covering NAD+, sermorelin, glutathione and B12.

Pricing is among the lowest in this market: $97 for a GLP-1 injection and $77 for a GLP-1 microdose, with NAD+, glutathione, MIC+B12 and B12 injections at $179 and sermorelin at $175. Included are a free online consultation with board-certified physician review, free discreet delivery, a patient portal for provider messaging, and itemised receipts for HSA or FSA reimbursement — a small touch that saves real money and which most competitors do not bother with.

Two operational details genuinely distinguish it. Medication ships in temperature-controlled packaging, which for peptide products is the correct standard and something several providers we have reviewed this month fail at. And Ivy Rx publicly names its pharmacy partners, with independent verification in FDA- and DEA-registered laboratories. Across more than forty reviews in this market, we have consistently flagged the inability to identify who actually compounds your injectable. Ivy Rx is the exception.

Its regulatory disclosure is also present and reasonably direct: compounded medications 'may be prescribed by physicians, but have not been FDA-regulated for safety, effectiveness, or quality', and 'the FDA does not review compounded medications for safety or effectiveness'. The BBB lists it at 111 1st Street, Miami, not accredited, with 33 complaints over three years — 29 closed in the last twelve months, 23 answered and 10 resolved.

Treatments & Pricing

Prices are Ivy Rx's published figures as at 7 August 2026, and they are quoted per treatment rather than clearly per month — confirm what period each price covers before subscribing. One detail worth crediting: the microdose at $77 costs less than the full dose at $97. Several competitors we have reviewed price their microdose protocols above their full-dose products, which makes no sense; Ivy Rx does not. That said, microdosing remains a commercial protocol without established outcome evidence, so cheaper is not the same as worthwhile.

Compounded or FDA-Approved — and Who Actually Makes It

Ivy Rx sells both compounded and brand-name products, which gives a genuine choice about regulatory risk. Ozempic, Mounjaro and metformin are FDA-approved; the compounded GLP-1s, NAD+, sermorelin and glutathione are not.

Its disclosure is clear enough: compounded medications 'have not been FDA-regulated for safety, effectiveness, or quality', and 'the FDA does not review compounded medications for safety or effectiveness'. Strictly, compounding is regulated — by state boards and, for outsourcing facilities, federally — it is the drug that is not approved. But the substance of the warning is right and it does not overclaim.

The genuinely notable thing is that Ivy Rx names its pharmacy partners publicly and says products are independently verified in FDA- and DEA-registered laboratories. Throughout this series we have repeatedly noted that buyers cannot check the inspection record of the facility making their injectable because the pharmacy is never named. Ivy Rx naming its partners means you can actually look them up — which is the single most useful transparency measure available in compounded telehealth, and it is rare enough to be worth choosing a provider for.

The longevity line deserves the same scepticism we apply elsewhere. NAD+ at $179 has essentially no controlled human outcome evidence for the energy and anti-ageing claims attached to it, sermorelin has no FDA approval for adult body composition, sleep or recovery use and warrants caution in anyone with a cancer history, and MIC+B12 lipotropic injections have repeatedly failed to show meaningful weight-loss benefit in people who are not deficient.

The Consultation Process

Eligibility

• •Eligibility is determined by a board-certified physician after a free online medical evaluation. No lab work is described as a requirement and states served are not published.
• •This is the most important paragraph on the page. A BBB complainant describes receiving incorrect injection instructions and states: 'I wound up injecting almost double the dose of GLP1 for two weeks before realizing.' Whatever the cause, the lesson for any reader is concrete — when your medication arrives, check the concentration on the vial against the volume you have been told to draw, and confirm the arithmetic with the prescriber before your first injection. Compounded GLP-1s come in varying concentrations, and a dosing instruction that assumes the wrong one is an easy and dangerous error.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive.
• •Clinician judgement is required for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy.
• •Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — and are worst after a dose increase. Doubling a dose inadvertently makes all of them considerably worse and raises the risk of dehydration and pancreatitis.
• •Sermorelin acts on the growth hormone/IGF-1 axis and warrants real caution in anyone with a history of cancer. Metformin requires awareness of renal function.
• •If you experience severe or persistent vomiting, severe abdominal pain radiating to the back, or signs of dehydration, stop and seek medical attention rather than continuing to dose.

Clinicians, Testing & Pharmacy Partners

Shipping & Support Services

Free, discreet and temperature-controlled — the correct handling for peptide medication and something several providers we have reviewed this month get wrong. The weakness is speed and communication: BBB complainants report unresolved delivery issues and missing tracking information, and independent coverage cites waits of up to 14 days against advertised same-day turnaround. Do not let an existing supply run out.

• •Among the lowest published pricing in the market — $97 GLP-1, $77 microdose
• •Names its pharmacy partners publicly, which almost no compounded provider does
• •Independent verification in FDA- and DEA-registered laboratories
• •Temperature-controlled shipping included free
• •Both compounded and brand-name options including Ozempic and Mounjaro
• •Free online consultation with board-certified physician review — no charge until prescribed
• •Itemised receipts provided for HSA/FSA reimbursement
• •Microdose priced below full dose, unlike several competitors
• •Founded by a PharmD; answers most BBB complaints
• •Around 4.0–4.5 on Trustpilot across roughly 4,000–5,100 reviews

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Ivy Rx May Be Best For

• •Price-driven buyers who want the cheapest compounded GLP-1 and value knowing which pharmacy compounds it
• •Anyone who has had medication arrive warm elsewhere and wants stated temperature-controlled shipping
• •People paying with HSA or FSA funds who want itemised receipts provided as standard
• •Patients who may want to move between compounded and brand-name without changing provider

Limitations

• •The dosing complaint is the one we would not look past, and it generalises beyond this provider. A customer describing two weeks of near-double GLP-1 dosing after following the instructions they were given is describing a medication error with real clinical consequences — worse nausea and vomiting, dehydration risk, and a raised risk of pancreatitis. Compounded GLP-1s are supplied at varying concentrations, and an instruction that assumes the wrong one produces exactly this. Whoever you buy from, check the concentration printed on the vial against the volume you have been told to draw, and have the prescriber confirm the arithmetic before your first injection.
• •The no-returns policy is the second problem, and it is broader than federal law requires. Dispensed medication genuinely cannot be returned — but a blanket statement that the company is 'unable to accept returns', with no window and no distinction between shipped and unshipped orders, removes any published entitlement even where nothing has left the pharmacy. Combined with reports of charges landing after cancellation, that puts the burden entirely on the customer to escalate.
• •The cancellation failures are the most common complaint and the easiest to guard against. Cancel in writing, keep the timestamp, and check the next statement — a customer charged $197 a week after cancelling had no way to recover it under the published policy.
• •Set against all of that, Ivy Rx does something no other provider in this series does: it tells you which pharmacy makes your medication. We have written the sentence 'you cannot check the inspection record of the facility preparing your injectable' more than thirty times in this batch. Ivy Rx is the exception, and for a compounded product that is a more meaningful safeguard than any marketing claim.
• •The longevity line is where we would spend least. NAD+, glutathione and MIC+B12 at $179 each rest on very limited evidence for the benefits marketed, and sermorelin at $175 has no approval for adult body composition use. The GLP-1 offering is the reason to consider this provider; the rest of the catalogue is not.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Ivy Rx does one thing no other provider in this entire series does: it tells you which pharmacy compounds your medication, and says the products are independently verified in FDA- and DEA-registered laboratories. We have written some version of 'the compounding pharmacy is not named, so you cannot check its inspection record' more than thirty times across these reviews. Removing that unknown is worth more than most of what companies in this market advertise, and it comes alongside genuinely low pricing at $97, temperature-controlled shipping, a free consultation, brand-name options, and itemised HSA/FSA receipts.

What holds it back is what happens after you pay. A blanket 'we are unable to accept returns' with no window and no distinction between shipped and unshipped orders leaves nothing to fall back on, and the complaint record shows why that matters — a customer charged $197 a week after cancelling, others charged twice for single orders, cancellation requests ignored, and delivery delays running to 14 days against an advertised same-day promise.

The complaint that concerns us most is clinical rather than commercial. A customer describing two weeks of near-double GLP-1 dosing after following the instructions they were given is describing a medication error, and the consequences of that error — severe nausea, dehydration, raised pancreatitis risk — are not trivial. The practical lesson applies wherever you buy: check the concentration on the vial against the volume you are told to draw, and make the prescriber confirm the arithmetic before your first injection.

We rate Ivy Rx 2.9 out of 5. The cheapest well-sourced compounded GLP-1 we have found, from the only provider willing to say who makes it, undercut by exit terms that give you nothing and an administrative record that includes both billing and dosing errors. If you use it, verify your dose in writing, cancel in writing, and skip the $175–$179 longevity line entirely — that part of the catalogue is priced well above its evidence.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved and have not been evaluated for safety, effectiveness or quality. Speak to a licensed clinician about whether treatment is appropriate for you before starting, changing or stopping any medication.